Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Postoperative mortality in elderly patients with colorectal cancer: The impact of age, time-trends and competing risks of dying.

Bos ACRK, Kortbeek D, van Erning FN, Zimmerman DDE, Lemmens VEPP, Dekker JWT, Maas HAAM.

Eur J Surg Oncol. 2019 Sep;45(9):1575-1583. doi: 10.1016/j.ejso.2019.04.020. Epub 2019 Apr 25.

PMID:
31053476
2.

Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis.

Mazzotti F, Cucchetti A, Claassen YHM, Bos ACRK, Bastiaannet E, Ercolani G, Dekker JWT.

World J Surg. 2019 Aug;43(8):2077-2085. doi: 10.1007/s00268-019-04978-0.

PMID:
30863872
3.

An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients.

Brouwer NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, Hugen N, Nagtegaal ID, de Wilt JHW, Verhoeven RHA.

Int J Cancer. 2018 Dec 1;143(11):2758-2766. doi: 10.1002/ijc.31785. Epub 2018 Sep 29.

4.

Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

van der Vlugt M, Grobbee EJ, Bossuyt PM, Bos ACRK, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1237-1243.e2. doi: 10.1016/j.cgh.2018.01.037. Epub 2018 Feb 7.

PMID:
29427732
5.

Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.

Bos ACRK, Matthijsen RA, van Erning FN, van Oijen MGH, Rutten HJT, Lemmens VEPP.

Ann Surg Oncol. 2018 Feb;25(2):414-421. doi: 10.1245/s10434-017-6255-y. Epub 2017 Nov 20.

PMID:
29159744
6.

Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?

Bos AC, Mouton JW, van Westreenen M, Andrinopoulou ER, Janssens HM, Tiddens HAWM.

J Antimicrob Chemother. 2017 Dec 1;72(12):3435-3442. doi: 10.1093/jac/dkx293.

PMID:
29029057
7.

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

Fles R, Bos ACRK, Supriyati, Rachmawati D, Waliyanti E, Tan IB, Haryana SM, Schmidt MK, Dewi FST.

BMC Public Health. 2017 May 25;17(1):510. doi: 10.1186/s12889-017-4429-y.

8.

The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?

Bos AC, Passé KM, Mouton JW, Janssens HM, Tiddens HA.

J Cyst Fibros. 2017 Jan;16(1):13-23. doi: 10.1016/j.jcf.2016.10.001. Epub 2016 Oct 26. Review.

9.

No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.

Bos AC, van Erning FN, Elferink MA, Rutten HJ, van Oijen MG, de Wilt JH, Lemmens VE.

Dis Colon Rectum. 2016 Oct;59(10):943-52. doi: 10.1097/DCR.0000000000000660.

PMID:
27602925
10.

Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis.

Bos AC, Tiddens HA, Tong Minh K, Heeres I, Overweel-Uijterlinde JL, Kok AE, Andrinopoulou ER, Janssens HM.

J Cyst Fibros. 2016 Sep;15(5):645-51. doi: 10.1016/j.jcf.2016.03.005. Epub 2016 Mar 24.

11.

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.

van Velzen AJ, Bos AC, Touw DJ, Tiddens HA, Heijerman HG, Janssens HM.

J Aerosol Med Pulm Drug Deliv. 2016 Jun;29(3):273-80. doi: 10.1089/jamp.2015.1259. Epub 2015 Dec 30.

PMID:
26716357
12.

RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.

van Erning FN, Elferink MA, Bos AC, Lemmens VE.

J Natl Cancer Inst. 2015 Sep;107(9). doi: 10.1093/jnci/djv203. No abstract available.

13.

Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.

Bos AC, van Erning FN, van Gestel YR, Creemers GJ, Punt CJ, van Oijen MG, Lemmens VE.

Eur J Cancer. 2015 Nov;51(17):2553-61. doi: 10.1016/j.ejca.2015.08.016. Epub 2015 Sep 7.

PMID:
26360411
14.

Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?

Bos AC, van Holsbeke C, de Backer JW, van Westreenen M, Janssens HM, Vos WG, Tiddens HA.

PLoS One. 2015 Mar 3;10(3):e0118454. doi: 10.1371/journal.pone.0118454. eCollection 2015.

15.

Inhaled antibiotics: dry or wet?

Tiddens HA, Bos AC, Mouton JW, Devadason S, Janssens HM.

Eur Respir J. 2014 Nov;44(5):1308-18. doi: 10.1183/09031936.00090314. Epub 2014 Oct 16. Review.

16.

Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis.

Tepper LA, Utens EM, Caudri D, Bos AC, Gonzalez-Graniel K, Duivenvoorden HJ, van der Wiel EC, Quittner AL, Tiddens HA.

Eur Respir J. 2013 Aug;42(2):371-9. doi: 10.1183/09031936.00137612. Epub 2013 Jan 11.

17.

Bordetella species in children with cystic fibrosis: what do we know? The role in acute exacerbations and chronic course.

Bos AC, Beemsterboer P, Wolfs TF, Versteegh FG, Arets HG.

J Cyst Fibros. 2011 Sep;10(5):307-12. doi: 10.1016/j.jcf.2011.06.003. Epub 2011 Jun 29. Review.

18.

Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages.

de Winther MP, van Dijk KW, van Vlijmen BJ, Gijbels MJ, Heus JJ, Wijers ER, van den Bos AC, Breuer M, Frants RR, Havekes LM, Hofker MH.

Atherosclerosis. 1999 Dec;147(2):339-47.

PMID:
10559520

Supplemental Content

Support Center